Cytodyn Inc (CYDY)

[misiu143]

I will suggest to read protocol of our CD12 study .

It showed it has 2 groups of patients .

Group A - severe ,
Group B - critical

Those are not some subgroups discovered after study was finished .

Those are 2 defined groups , in a protocol approved by the FDA .,

And even with 2 doses showed that Leronlimab, without a question is saving lives at least in group B, critical .

And since so many are dying without one good drug approved for this group of patients .
Group B from CD12 protocol should have EUA or approval with phase 4 at the end of this study ..

No , not the Biogen Alz drug , but Leronlimab should be approved then ..

Many lives will be saved by now ..

History will judge all this ..

Imo